Order:
  1.  55
    Ethical Issues in Neurografting of Human Embryonic Cells.G. J. Boer - 1999 - Theoretical Medicine and Bioethics 20 (5):461-475.
    During the last decade neurotransplantation has developed into a technique with the possible potential to repair damaged or degenerating human brain. Effective neurotransplantation has so far been based on the use of fetal brain tissue derived from aborted embryos or fetuses. The ethical issues related to this new therapeutic approach therefore not only concern the possible adverse side effects for a neural graft-receiving patient, but also the relationship between the requirements for fetal tissue and the decision-making process for induced abortion. (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  2. Transplantation and Xenotransplantation.G. J. Boer - 2010 - In James J. Giordano & Bert Gordijn (eds.), Scientific and Philosophical Perspectives in Neuroethics. Cambridge University Press.
     
    Export citation  
     
    Bookmark  
  3. Index to Volume 20.Zlatko Anguelov, Piero Antuono, Jan Beyer, G. J. Boer, David J. Casarett, David Checkland, Jan De Lepeleire, Pieter F. De Vries Robbé, Arthur R. Derse & Edmund L. Erde - 1999 - Theoretical Medicine and Bioethics 20:599-603.
     
    Export citation  
     
    Bookmark  
  4.  41
    Ethical Guidance on Human Embryonic and Fetal Tissue Transplantation: A European Overview.G. de Wert, R. L. P. Berghmans, G. J. Boer, S. Andersen, B. Brambati, A. S. Carvalho, K. Dierickx, S. Elliston, P. Nunez, W. Osswald & M. Vicari - 2002 - Medicine, Health Care and Philosophy 5 (1):79-90.
    This article presents an overview ofregulations, guidelines and societal debates ineight member states of the EC about a)embryonic and fetal tissue transplantation(EFTT), and b) the use of human embryonic stemcells (hES cells) for research into celltherapy, including `therapeutic' cloning. Thereappears to be a broad acceptance of EFTT inthese countries. In most countries guidance hasbeen developed. There is a `strong' consensusabout some of the central conditions for `goodclinical practice' regarding EFTT.International differences concern, amongstothers, some of the informed consent issuesinvolved, and the (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation